Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers S P 500 2x Leveraged Daily Swap UCITS ETF 1c
LU0411078552 · LU0411078552 · USD · domicile Luxembourg
Equity · United States · Large capleveraged 2xSFDR art. 6 (inferred)
Index tracked: S&P 500 2X LEVERAGED DAILY INDEX (USD)
- TER
- 0.60%+ trans. 0.00%
- Fund size
- 550 m EUR
- Tracking difference
- −0.52%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 18 Mar 2010 · costs from the KID as of 2 Sept 2026 · 46 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. "
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the S&P 500 2x Leveraged Daily Index (index) which provides two times the performance of the S&P 500 Index (Underlying Index) on a daily basis less a rate of interest.
DESCRIPTION OF INDEX:
This means that the level of the index should rise and fall at double the rate of the Underlying Index. The interest rate taken from the Reference Index level is based on the rate at which institutions can borrow US dollars overnight while posting US…
Performance since series start (in euro) — base 100
18 Mar 2010 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +35.1% |
| 3 years | +132.2% |
| 5 years | +128.7% |
| 10 years | +703.8% |
| Since series start | +3,250.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 25.34% | 29.49% | 33.94% |
| Max drawdown | −18.06% | −35.14% | −46.44% |
| Sharpe | 1.17 | 1.06 | 0.57 |
| Sortino | 1.69 | 1.55 | 0.83 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0411078552 · LU04110785521
RebalixLU0411078552 · LU0411078552 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +27.11% | +27.62% | −0.51% |
| 2024 | +44.12% | +44.67% | −0.54% |
| 2023 | +47.06% | +47.56% | −0.50% |
| 2022 | −38.57% | −38.41% | −0.16% |
| 2021 | +60.51% | +61.30% | −0.79% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 46 securities · top-10 weight = 50.7%
| Top holdings | Weight |
|---|---|
| 6.9% | |
| 6.2% | |
| 5.8% | |
| 5.2% | |
| 4.6% | |
| 4.6% | |
| 4.5% | |
| 4.4% | |
| 4.3% | |
| 4.2% |
Listing venues
ESMA register (FIRDS) and official exchange lists
XS2L · Borsa Italiana (ETFplus)
DBPG · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 20 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU0411078552
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0411078552
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU0411078552 · LU04110785522